Lateral Nodal Recurrence in Rectal Cancer
Condition(s):Rectal CancerLast Updated:January 19, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):Rectal CancerLast Updated:January 19, 2023Recruiting
Condition(s):Gastric CancerLast Updated:March 6, 2024Recruiting
Condition(s):Recurrent MiscarriageLast Updated:February 8, 2024Not yet recruiting
Condition(s):Locoregional Recurrence; Hormone Receptor-positive Breast Cancer; HER2-negative Breast CancerLast Updated:January 5, 2024Recruiting
Condition(s):Recurrent Breast CancerLast Updated:March 25, 2024Recruiting
Condition(s):Non-Muscle Invasive Bladder CancerLast Updated:February 5, 2024Recruiting
Condition(s):FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma; FIGO Grade 2 Endometrial Endometrioid AdenocarcinomaLast Updated:February 28, 2024Recruiting
Condition(s):Pancreatic Ductal Adenocarcinoma; Pancreatic Cancer; Pancreas Cancer; PDACLast Updated:February 2, 2023Recruiting
Condition(s):Hepatocellular Carcinoma; LenvatinibLast Updated:February 6, 2023Recruiting
Condition(s):Venous Thromboembolism; Venous Thromboses; Pulmonary Embolism; Deep Vein ThrombosisLast Updated:December 22, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.